Taysha Gene Therapies
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TSHA and other ETFs, options, and stocks.About TSHA
Taysha Gene Therapies, Inc. is a clinical-stage biotechnology company, which engages in the development and commercialization of adeno-associated viruses (AAV) based gene therapies for the treatment of monogenic diseases of the central nervous system. It also develops multiple gene therapy platforms which include AAV9 Discovery, Novel Capsid, and AAV Redosing.
TSHA Key Statistics
Stock Snapshot
The current Taysha Gene Therapies(TSHA) stock price is $6.39, with a market capitalization of 2.24B. The stock trades at a price-to-earnings (P/E) ratio of -16.00.
During the trading session on 2026-08-07, Taysha Gene Therapies(TSHA) shares reached a daily high of $6.48 and a low of $6.35. At a current price of $6.39, the stock is +0.6% higher than the low and still -1.4% under the high.
Trading volume for Taysha Gene Therapies(TSHA) stock has reached 421.17K, versus its average volume of 2.51M.
The stock's 52-week range extends from a low of $2.69 to a high of $7.30.
The stock's 52-week range extends from a low of $2.69 to a high of $7.30.
Analyst ratings
100%
of 12 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.